ABVX – abivax sa - american depositary shares (US:NASDAQ)
Stock Stats
News
Abivax (ABVX) had its "buy" rating reaffirmed by BTIG Research. They now have a $150.00 price target on the stock.
Abivax (NASDAQ:ABVX) is now covered by analysts at Wedbush. They set an "underperform" rating on the stock.
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Better Long-Term Buy: This Emerging Player or the Industry Leader? [Yahoo! Finance]
Prediction: This Healthcare Stock Could Soar by 72% in 2026 [Yahoo! Finance]
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.